Enpp-1-IN-16
Product Specifications
UNSPSC Description
Enpp-1-IN-16 (compound 54) is an ENPP1 inhibitor. Enpp-1-IN-16 has the potential to study cancer, especially in cases of high ENPP1 expression or elevated cytoplasmic DNA levels. Enpp-1-IN-16 can also be used in other diseases mediated by ENPP1, such as bacterial or viral infections, insulin resistance and type II diabetes, chondrocalcinosis and osteoarthritis, calcium pyrophosphate deposition disorder (CPPD), low Phosphatase disease and soft tissue calcification disorders[1].
Target Antigen
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/enpp-1-in-16.html
Solubility
DMSO : 2 mg/mL (ultrasonic)
Smiles
O=C(N1CCC2(CCN(CC2)C3=C4C=C(OC)C(OC)=CC4=NC=N3)C1)OC(C)(C)C
Molecular Weight
428.52
References & Citations
[1]Derek A Cogan, et al. Imino sulfanone inhibitors of enpp1. WO2021225969A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153335/Enpp-1-IN-16-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153335/Enpp-1-IN-16-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2289739-47-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
